Edward Samuel

Ed serves as EVP Technical Operations at Achilles and has more than 16 years of industry and academic experience in process development, technology transfer, GMP manufacturing and regulatory affairs in the field of cell and gene therapy. Before joining Achilles, he was the Cell Therapy Operations Manager for Europe at Orchard Therapeutics where he was responsible for establishing the supply-chain infrastructure to support cell therapy manufacturing and regulatory submissions in the US and Europe. Previously, Ed held positions at Cognate BioServices Ltd as Director for Manufacturing and in post-doctoral translational research at University College London (UCL). He holds a PhD in T cell immunology and transplantation from UCL, and an MSc in Medical Immunology from King’s College London.